Beroni Group has announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation. The assay targets on coronavirus-specific nanobodies and tests affinity and efficacy to prevent the ...
Beroni Group is collaborating with Forsitech and Standard Capital to supply its SARS-CoV-2 total antibody detection kit for clinical testing in the Japanese market.
Jinshui Park has agreed to provide the office facilities, related infrastructure, and local government guidance and support and Beroni will be responsible to develop and implement the business plan